Vnitr Lek 1999, 45(5):284-290

[Radiosurgery with the Leksell gamma knife in the treatment of solitary brain metastasis--5-year results].

G Simonová, R Liscák, J Novotný, J Novotný
Oddĕlení stereotaktické a radiacní neurochirurgie, Nemocnice Na Homolce, Praha.

During five years (1992-1997) 215 patients with solitary brain metastases were treated in the Department of Stereotactic and Radiation Neurosurgery (117 men and 98 women). The most frequent first neurological symptoms were: headache, hemiparesis, seizure, mental and behavioural disturbances. Location of lesion was supratentorial in 163 patients (75.8%) and infratentorial in 52 cases (24.2%). Treatment results: complete and partial regression in 175 patients (81.4%), stabilisation in 30 of patients (14.0%), local progression in 10 patients (4.6%). Local recurrence after initially effective treatment was observed in 11 pts (5.1%). The severity of neurological symptoms was measured by RTOG 4 grades scoring system. The acute and late toxicity was evaluated by SOMA scale (RTOG--Radiation Therapy Oncology Group): grading 0-5. We observed acute toxicity (score 3 and 4) in 20 patients (9.3%) and late (score 3 and 4) in 9 patients (4.2%). Minimal follow up for all patients was 10 months. Median survival for 159 dead patients was 7 months (ranged from 2 to 35 months), median survival for surviving 56 pts was 15.5 months (ranged from 10 to 56 months). One-year survival was 39.5% of all patients.

Keywords: Adult; Aged; Brain Neoplasms, diagnostic imaging, ; Female; Humans; Male; Middle Aged; Radionuclide Imaging; Radiosurgery; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome

Published: May 1, 1999  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Simonová G, Liscák R, Novotný J, Novotný J. [Radiosurgery with the Leksell gamma knife in the treatment of solitary brain metastasis--5-year results]. Vnitr Lek. 1999;45(5):284-290.
Download citation




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.